Syneron Candela Tattoo Removal Laser Receives FDA Approval

Syneron Medical, a leading global esthetic device company, announced recently that the U.S. Food and Drug Administration (FDA) cleared its new PicoWay picosecond device. The system was evaluated in a U.S. multicenter study conducted by Eric Bernstein, M.D., president of Main Line Center for Laser Surgery (Ardmore, PA), Arielle Kauvar, M.D., director of New York Laser & Skin Care, and Tina Alster, M.D., founding director of Washington Institute of Dermatologic Laser Surgery, and showed a favorable safety profile. This dual wavelength laser utilizes proprietary technology to generate picosecond (one trillionth of a second) pulses for the safe removal of tattoos. It is approved for all tattoo colors: red, yellow, and orange for the 532nm wavelength, and black, brown, green, blue, and purple for the 1064nm wavelength. In the study, a majority of participants achieved at least 50 percent tattoo clearance after three treatments. “PicoWay is an innovative and exciting breakthrough for tattoo removal,” says Bernstein. “It delivers extremely high peak-power, picosecond pulses enabling the treatment of all skin types. What this means is extremely impressive results, which translate into very happy patients. PicoWay is a game-changing laser for tattoo removal and could not have come at a better time.”—Jennifer Nied

Suggested Articles

The partnership will help market and distribute Neauvia North America's Plasma IQ.

Gates has extensive experience in the consumer product arena.

The new channels are being developed for the roll-out of its novel technology to improve fine lines and wrinkles on the face and neck.